Kulicke and Soffa

Kulicke and Soffa is the most surprising AI-infrastructure beneficiary nobody talks about — a 73-year-old Singapore-headquartered semi-packaging equipment maker that builds the wire bonders, ball bonders, and (newly) advanced-packaging tools used to assemble every memory chip, automotive sensor, and increasingly every HBM3E and HBM4 stack shipped globally. The stock has 3x'd in 12 months from $31 to $102 — and the move is justified by Q3/FY26 revenue of $232M (+49.8% YoY), the company's fastest growth quarter since 2017.

The pivot story has three legs. First, K&S's thermo-compression bonding (TCB) equipment is now qualified at SK Hynix and Samsung for HBM die-stacking — a market K&S did not participate in 2 years ago. Second, the Q2/FY26 acquisition of CIRRA Semiconductor (closed October 2025 for $450M) added high-density interconnect substrate bonding capability for Co-Packaged Optics (CPO). Third, the legacy wire-bonder business benefits from a $1.4B Chinese automotive-semi capex wave through 2027.

K&S guides FY27 revenue at $1.1-1.2B with gross margins at 49-51% — both well above peer-cycle averages. The stock trades at forward P/E 24x — high for a Singapore semi-equipment maker but well below ASML at 28x and KLAC at 21x once you adjust for K&S's superior growth trajectory.

K&S has attracted concentrated active-manager interest after the HBM-TCB qualification. Capital Group (American Funds) held 5.8M shares per Q1/2026 13F — their fifth-largest single-name Singapore-listed holding. Wellington Management at 3.2M, State Street at 2.4M passive. D. E. Shaw built a 1.4M-share position split across stat-arb and value buckets.

The signal: Cohen & Steers Global Listed Infrastructure (a fund not normally in semi-equipment names) initiated 850,000 shares in Q4/2025 — flagging in their quarterly commentary that K&S deserves a separate basket allocation distinct from cyclical semi peers because of the HBM-TCB advanced-packaging exposure.

Insider activity (SEC Form 4): CEO Fusen Chen sold 35,000 shares in March 2026 at $98 (10b5-1 plan, ~$3.4M). CFO Lester Wong sold 18,000 shares same plan. No open-market insider buying for 2+ years. Insider ownership remains at 1.8%, normal for established semi-equipment.

K&S at 24x forward P/E and 5.4x EV/sales on FY27 consensus trades at a premium to Singapore peers but a meaningful discount to ASML and KLAC. The closest pure-play comparison is ASMPT (Asia-listed) which trades at 16x forward P/E with similar growth profile — implying K&S has a 50% premium. Sum-of-parts on segment economics: wire-bonder business at 12x EBITDA = $2.2B, advanced-packaging (TCB+CPO) at 25x EBITDA = $2.4B, CIRRA Semi at 30x EBITDA = $700M = $5.3B EV less $200M net debt = $5.1B equity value. That arrives at $98 per share — modestly below today's $102. Bull case with HBM-TCB capturing 50% share: $130-145. Bear case with CIRRA integration slips and Samsung HBM4 delay: $70-78. Risk-reward is finely balanced at current levels.

1. May 7, 2026: Q3/FY26 earnings — first full quarter of CIRRA Semiconductor integration; consensus revenue $251M, EPS $0.85
2. August 6, 2026: Q4/FY26 earnings — typical guidance update for FY27; bull case requires explicit $1.2B+ revenue framing
3. Q1 2027: Samsung Pyeongtaek HBM4 production-ramp commercial deliveries — K&S TCB-related revenue inflection visible by end of Q1/FY27

K&S is the rare situation where a sleepy legacy semi-equipment maker has executed a genuine technology pivot — and the market has noticed but not fully priced it. I size this as a 1.5% position in a thematic semi-equipment sleeve, alongside ASML and Lam Research. The risk-reward is now skewed: every additional 10% upside requires HBM-TCB share gains, while a single bad quarter at SK Hynix or Samsung produces 25% downside. My personal trigger to upsize is a pullback to $78-82 (an 18-20% drawdown) which would put forward P/E back to ~19x — the historical 5-year average. At $102 today, I rate it a hold-but-don't-add. Watching HBM-TCB market-share data more than the quarterly numbers.